Viking Therapeutics, Inc.

VKTX · Healthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…

Viking Therapeutics, Inc. (VKTX), in the Healthcare sector, has 12 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 1 purchase and 11 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Jul 29 and filed Jul 30. The most active filer was Greg Zante with 6 filings.

Add to watchlist

Filings, ttm

1 buy · 11 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$22.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jul 29

Filed Jul 29

ADViAverage daily dollar volume

$77.4M

market data

Share price · 12M

$33.37 (+27.1%)

Adjusted for splits and dividends.

Volume by month

Buys $150K Sells $48.2M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Greg Zante Chief Financial Officer 6 filings BL

Brian Lian President & CEO 5 filings MM

Marianna Mancini Chief Operating Officer 5 filings NA

Neil William Aubuchon Chief Commercial Officer 1 filing MF Matthew W Foehr President and CEO 1 filing LM

Lawson Macartney Director 1 filing SR

Sarah Kathryn Rouan Director 1 filing CJ

Charles A Rowland Jr Director 1 filing

Recent filings

Brian LianSALE President & CEO $4.9M
148,517 sh × $33.32
Exec Jul 29
Filed Jul 29 · 8:07 PM ET Greg ZanteSALE Chief Financial Officer $710K
21,217 sh × $33.47
Exec Jul 29
Filed Jul 29 · 8:06 PM ET Marianna ManciniSALE Chief Operating Officer $610K
18,217 sh × $33.47
Exec Jul 29
Filed Jul 29 · 8:06 PM ET Neil William AubuchonPURCHASE Chief Commercial Officer $150K
4,475 sh × $33.50
Exec Mar 10
Filed Mar 10 · 6:20 PM ET Matthew W FoehrSALE Director $562K
16,000 sh × $35.11
Exec Jan 2
Filed Jan 5 · 5:30 PM ET Brian LianSALE President & CEO $7.7M
233,409 sh across 4 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Marianna ManciniSALE Chief Operating Officer $1.8M
56,061 sh across 3 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Greg ZanteSALE Chief Financial Officer $1.8M
56,161 sh across 3 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Greg ZanteSALE Chief Financial Officer $216K
6,185 sh × $35.00
Exec Oct 28 2025
Filed Oct 28 2025 · 5:30 PM ET Brian LianSALE President & CEO $1.4M
38,989 sh × $35.01
Exec Oct 28 2025
Filed Oct 28 2025 · 5:30 PM ET Charles A Rowland JrSALE Director $2.1M
60,000 sh × $35.57
Exec Oct 27 2025
Filed Oct 28 2025 · 5:30 PM ET Marianna ManciniSALE Chief Operating Officer $216K
6,185 sh × $35.00
Exec Oct 28 2025
Filed Oct 28 2025 · 5:30 PM ET Marianna ManciniSALE Chief Operating Officer $118K
4,266 sh × $27.77
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET Greg ZanteSALE Chief Financial Officer $118K
4,266 sh × $27.76
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET Brian LianSALE President & CEO $748K
26,889 sh × $27.80
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET Greg ZanteSALE Chief Financial Officer $2.2M
50,309 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET Marianna ManciniSALE Chief Operating Officer $2.3M
54,215 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET Brian LianSALE President & CEO $8.3M
194,490 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET Lawson MacartneySALE Director $137K
2,000 sh × $68.67
Exec Nov 8 2024
Filed Nov 8 2024 · 5:30 PM ET Greg ZanteSALE Chief Financial Officer $10.0M
130,481 sh across 7 lots
Exec Oct 28 2024
Filed Oct 28 2024 · 5:30 PM ET J Matthew SingletonSALE Director $1.3M
16,000 sh × $79.50
Exec Oct 25 2024
Filed Oct 25 2024 · 5:30 PM ET Sarah Kathryn RouanSALE Director $890K
11,000 sh × $80.89
Exec Oct 25 2024
Filed Oct 25 2024 · 5:30 PM ET Brian LianSALE President & CEO $15.3M
215,930 sh across 2 lots
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET J Matthew SingletonSALE Director $716K
10,300 sh × $69.50
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET